Inventor

Anita Wiebe

Inventor

Ruebgarten, DE

Overview

2018–2021

Patent span

Chemistry

Primary field (CPC C)

Patents· 51 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes20%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%

C07KPeptides20%

C12NMicroorganisms or enzymes20%

G01NInvestigating or analysing materials by determining their chemical or physical properties15%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5%

PatentTitleYear

11,123,370Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers2021 11,117,951Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers2021 11,083,784Peptides and combination of peptides for use in immunotherapy against CLL and other cancers2021 11,058,726Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers2021 10,842,817Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers2020 10,835,587Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers2020 10,835,588Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers2020 10,813,986Peptides and combination of peptides for use in immunotherapy against NHL and other cancers2020 10,799,570Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers2020 10,780,125Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers2020 10,722,566Peptides and combination of peptides for use in immunotherapy against CLL and other cancers2020 10,722,565Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers2020 10,722,536Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers2020 10,702,592Peptides and combination of peptides for use in immunotherapy against NHL and other cancers2020 10,702,593Peptides and combination of peptides for use in immunotherapy against NHL and other cancers2020 10,688,131Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers2020 10,683,337Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers2020 10,668,100Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers2020 10,669,326Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers2020 10,653,761Peptides and combination of peptides for use in immunotherapy against CLL and other cancers2020 10,653,762Peptides and combination of peptides for use in immunotherapy against CLL and other cancers2020 10,596,240Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers2020 10,596,241Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers2020 10,596,196Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers2020 10,526,386Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers2020 10,525,084Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers2020 10,513,547Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers2019 10,472,407Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers2019 10,464,990Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers2019 10,457,712Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers2019 10,442,844Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers2019 10,435,448Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers2019 10,398,766Peptides and combination of peptides for use in immunotherapy against CLL and other cancers2019 10,377,811Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers2019 10,363,295Peptides and combination of peptides for use in immunotherapy against NHL and other cancers2019 10,357,550Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers2019 10,335,475Peptides and combination of peptides for use in immunotherapy against NHL and other cancers2019 10,335,474Peptides and combination of peptides for use in immunotherapy against CLL and other cancers2019 10,314,898Peptides and combination of peptides for use in immunotherapy against NHL and other cancers2019 10,293,036Peptides and combination of peptides for use in immunotherapy against NHL and other cancers2019 10,272,114Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers2019 10,238,724Peptides and combination of peptides for use in immunotherapy against CLL and other cancers2019 10,238,726Peptides and combination of peptides for use in immunotherapy against CLL and other cancers2019 10,239,931Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers2019 10,238,691Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers2019 10,238,725Peptides and combination of peptides for use in immunotherapy against CLL and other cancers2019 10,221,225Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers2019 10,195,232Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers2019 10,117,916Peptides and combination of peptides for use in immunotherapy against CLL and other cancers2018 10,064,928Peptides and combination of peptides for use in immunotherapy against CLL and other cancers2018 10,064,926Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers2018

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2018–2021Patents assigned to IMMATICS BIOTECHNOLOGIES GMBH (51)· patent assignee history

2018–2020Based in Pliezhausen, DE· patent location history

2019–2021Based in Ruebgarten, DE· patent location history

2019–2021Based in Rübgarten, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
IMMATICS BIOTECHNOLOGIES GMBH	51	2018–2021

Locations

Location	Patents	Span
Ruebgarten, DE	33	2019–2021
Rübgarten, DE	9	2019–2021
Pliezhausen, DE	9	2018–2020